Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues
Published on: January 12, 2024
A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood-brain barrier
Adrien Mossu1, Maria Rosito1, Tejas Khire2
11 Theodor Kocher Institute, University of Bern, Bern, Switzerland.
Abstract:
Here we report on the development of a breakthrough microfluidic human in vitro cerebrovascular barrier (CVB) model featuring stem cell-derived brain-like endothelial cells (BLECs) and nanoporous silicon nitride (NPN) membranes (µSiM-CVB). The nanoscale thinness of NPN membranes combined with their high permeability and optical transparency makes them an ideal scaffold for the assembly of an in vitro microfluidic model of the blood-brain barrier (BBB) featuring cellular elements of the neurovascular unit (NVU). Dual-chamber devices divided by NPN membranes yield tight barrier properties in BLECs and allow an abluminal pericyte-co-culture to be replaced with pericyte-conditioned media. With the benefit of physiological flow and superior imaging quality, the µSiM-CVB platform captures each phase of the multi-step T-cell migration across the BBB in live cell imaging. The small volume of <100 µL of the µSiM-CVB will enable in vitro investigations of rare patient-derived immune cells with the human BBB. The µSiM-CVB is a breakthrough in vitro human BBB model to enable live and high-quality imaging of human immune cell interactions with the BBB under physiological flow. We expect it to become a valuable new tool for the study of cerebrovascular pathologies ranging from neuroinflammation to metastatic cancer.
Related Concept Videos
The Blood-brain Barrier
Blood Flow
What is the Immune System?
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Applications of Integration to Find Blood Flow
Humoral Immune Responses

